SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 398 filers reported holding SEATTLE GENETICS INC in Q4 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $16,091,000 | +603.0% | 84,807 | +528.4% | 0.07% | +407.1% |
Q2 2020 | $2,289,000 | -5.6% | 13,496 | -36.5% | 0.01% | -26.3% |
Q1 2020 | $2,426,000 | +126.3% | 21,265 | +124.3% | 0.02% | +171.4% |
Q4 2019 | $1,072,000 | -87.0% | 9,480 | -91.1% | 0.01% | -86.3% |
Q3 2019 | $8,221,000 | -43.8% | 107,041 | -50.7% | 0.05% | -30.1% |
Q2 2019 | $14,635,000 | +226.9% | 216,959 | +275.8% | 0.07% | +170.4% |
Q1 2019 | $4,477,000 | +41.1% | 57,725 | +3.5% | 0.03% | +28.6% |
Q4 2018 | $3,172,000 | -29.1% | 55,778 | -3.4% | 0.02% | -19.2% |
Q3 2018 | $4,477,000 | +18.7% | 57,725 | +0.3% | 0.03% | +4.0% |
Q2 2018 | $3,772,000 | -12.6% | 57,545 | -30.6% | 0.02% | -16.7% |
Q1 2018 | $4,318,000 | +7.9% | 82,866 | -1.7% | 0.03% | -3.2% |
Q4 2017 | $4,002,000 | 0.0% | 84,337 | 0.0% | 0.03% | 0.0% |
Q3 2017 | $4,002,000 | -11.4% | 84,337 | -0.2% | 0.03% | -13.9% |
Q2 2017 | $4,516,000 | -16.7% | 84,501 | -1.5% | 0.04% | -28.0% |
Q1 2017 | $5,423,000 | +15.6% | 85,749 | -2.9% | 0.05% | 0.0% |
Q4 2016 | $4,691,000 | +167.9% | 88,350 | +168.9% | 0.05% | +163.2% |
Q3 2016 | $1,751,000 | -1.8% | 32,850 | -25.7% | 0.02% | -5.0% |
Q2 2016 | $1,784,000 | -11.8% | 44,200 | -26.5% | 0.02% | -16.7% |
Q1 2016 | $2,022,000 | -36.9% | 60,100 | -15.2% | 0.02% | -35.1% |
Q4 2015 | $3,203,000 | +32.2% | 70,900 | +12.9% | 0.04% | +23.3% |
Q3 2015 | $2,422,000 | -17.3% | 62,800 | +3.8% | 0.03% | -14.3% |
Q2 2015 | $2,928,000 | +42.1% | 60,500 | +3.8% | 0.04% | +34.6% |
Q1 2015 | $2,061,000 | -3.6% | 58,300 | -11.9% | 0.03% | -3.7% |
Q4 2014 | $2,137,000 | -20.5% | 66,200 | -8.4% | 0.03% | -25.0% |
Q3 2014 | $2,688,000 | -0.4% | 72,300 | +2.4% | 0.04% | -12.2% |
Q2 2014 | $2,700,000 | -20.0% | 70,600 | -4.7% | 0.04% | -24.1% |
Q1 2014 | $3,376,000 | +20.9% | 74,100 | +6.8% | 0.05% | +17.4% |
Q4 2013 | $2,792,000 | -5.9% | 69,400 | +2.5% | 0.05% | -11.5% |
Q3 2013 | $2,967,000 | – | 67,700 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |